● Recruiting

Refusal of Sentinel Lymph Node Biopsy in Patients With Luminal A Subtype Early Breast Cancer

Condition: Early Breast Cancer · Sponsor: N.N. Petrov National Medical Research Center of Oncology

PhaseNA

Planned participants100

Who can joinFemale, 60 Years to no upper limit

Healthy volunteersNo

About this study

Sentinel lymph node biopsy (SLNB) is the standard of axillary lymph node surgical staging in patients with early breast cancer. The main goal of the study is to abandon axillary surgery in patients over 59 years old with early, luminal A, clinical lymph node negative breast cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Petr Krivorotko, Degree · +79219597722 · dr.krivorotko@mail.ru

Arina Gorina · +79185374992 · dr.arina_olegovna@mail.ru

Always discuss trial participation with your own doctor first.

Locations (1)

N.N. Petrov National Medical Research Center of Oncology

Saint Petersburg, Russian Federation, Russia

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07579286